adesso Valuation

Is ADN1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ADN1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ADN1 (€88) is trading above our estimate of fair value (€51.58)

Significantly Below Fair Value: ADN1 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ADN1?

Key metric: As ADN1 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ADN1. This is calculated by dividing ADN1's market cap by their current earnings.
What is ADN1's PE Ratio?
PE Ratio124.9x
Earnings€4.58m
Market Cap€571.85m

Price to Earnings Ratio vs Peers

How does ADN1's PE Ratio compare to its peers?

The above table shows the PE ratio for ADN1 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average20.5x
GFT GFT Technologies
12.1x12.3%€571.3m
COK Cancom
18x1.1%€728.0m
YSN secunet Security Networks
25.1x8.5%€694.8m
SHF SNP Schneider-Neureither & Partner
26.9x11.1%€383.1m
ADN1 adesso
124.9x42.3%€571.8m

Price-To-Earnings vs Peers: ADN1 is expensive based on its Price-To-Earnings Ratio (124.9x) compared to the peer average (20.5x).


Price to Earnings Ratio vs Industry

How does ADN1's PE Ratio compare vs other companies in the DE IT Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
ADN1 124.9xIndustry Avg. 17.9xNo. of Companies3PE01224364860+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ADN1 is expensive based on its Price-To-Earnings Ratio (124.9x) compared to the European IT industry average (17.9x).


Price to Earnings Ratio vs Fair Ratio

What is ADN1's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ADN1 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio124.9x
Fair PE Ratio27.2x

Price-To-Earnings vs Fair Ratio: ADN1 is expensive based on its Price-To-Earnings Ratio (124.9x) compared to the estimated Fair Price-To-Earnings Ratio (27.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ADN1 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€88.00
€122.67
+39.4%
28.3%€162.00€75.00n/a6
Nov ’25€65.90
€121.50
+84.4%
29.1%€160.00€75.00n/a6
Oct ’25€72.40
€121.50
+67.8%
29.1%€160.00€75.00n/a6
Sep ’25€66.10
€133.17
+101.5%
21.8%€160.00€80.00n/a6
Aug ’25€91.60
€153.33
+67.4%
20.8%€200.00€110.00n/a6
Jul ’25€82.50
€162.00
+96.4%
17.1%€200.00€120.00n/a5
Jun ’25€98.40
€172.50
+75.3%
11.7%€200.00€145.00n/a4
May ’25€109.40
€175.00
+60.0%
13.6%€210.00€145.00n/a4
Apr ’25€109.20
€173.75
+59.1%
14.0%€210.00€145.00n/a4
Mar ’25€116.00
€171.25
+47.6%
12.1%€200.00€145.00n/a4
Feb ’25€97.20
€169.00
+73.9%
10.5%€191.00€145.00n/a4
Jan ’25€107.40
€171.50
+59.7%
8.5%€191.00€155.00n/a4
Dec ’24€99.20
€171.50
+72.9%
8.5%€191.00€155.00n/a4
Nov ’24€87.30
€185.50
+112.5%
10.1%€205.00€155.00€65.904
Oct ’24€102.60
€185.50
+80.8%
10.1%€205.00€155.00€72.404
Sep ’24€114.20
€185.50
+62.4%
10.1%€205.00€155.00€66.104
Aug ’24€109.40
€202.75
+85.3%
7.8%€230.00€190.00€91.604
Jul ’24€123.80
€204.25
+65.0%
7.6%€230.00€190.00€82.504
Jun ’24€115.00
€204.25
+77.6%
7.6%€230.00€190.00€98.404
May ’24€135.60
€205.50
+51.5%
7.2%€230.00€190.00€109.404
Apr ’24€147.00
€200.00
+36.1%
4.0%€210.00€190.00€109.204
Mar ’24€153.60
€200.00
+30.2%
4.0%€210.00€190.00€116.004
Feb ’24€144.60
€200.00
+38.3%
4.0%€210.00€190.00€97.204
Jan ’24€131.80
€202.50
+53.6%
2.8%€210.00€195.00€107.404
Dec ’23€134.80
€202.50
+50.2%
2.8%€210.00€195.00€99.204
Nov ’23€102.00
€201.25
+97.3%
2.1%€205.00€195.00€87.304

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies